All Topics

Recent trade secret case law reveals critical standards for proving misappropriation, from the Ninth Circuit's reversal of a $57 million judgment over incorrect jury instructions on the "not readily ascertainable" element, to the Eighth Circuit's requirements for adequate trade secret identification. Courts continue to refine extraterritorial application of the DTSA and standards for demonstrating actual use of allegedly misappropriated information.

Former federal prosecutor Guy Singer joins host Eva Davis to discuss his transition to Winston Taylor, where he leads complex white-collar defense and internal investigations. The conversation explores how judgment, collaboration, and team-first leadership shape high-stakes legal work and client relationships in an era where technical excellence alone isn't enough.

The False Claims Act’s qui tam provisions are among the federal government’s most important tools for identifying and pursuing alleged fraud involving Medicare, Medicaid, federal health care programs and other government funds. The statute permits a private individual, known as a relator, to bring a False Claims Act action “for the person and for the United States Government” in the name of the government.